The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical characteristics, cytogenetic associations, and outcomes in multiple myeloma with chromosome 1q abnormalities.
 
Abdullah Ramzan
No Relationships to Disclose
 
Linda Baughn
Consulting or Advisory Role - Genentech
 
Prashant Kapoor
Honoraria - Abbvie (Inst); Abbvie (Inst); AstraZeneca; BeiGene; MustangBio; Pharmacyclics; Sanofi (Inst)
Consulting or Advisory Role - Sanofi (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Ichnos Sciences (Inst); Karyopharm Therapeutics (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Sanofi
 
Morie Gertz
Honoraria - Abbvie; Akcea Therapeutics; Alnylam; Amgen; Apellis Pharmaceuticals; Celgene; Janssen Oncology; Juno/Celgene; Med Learning Group; Prothena; Research to Practice; Sanofi; Telix Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Prothena
Travel, Accommodations, Expenses - Celgene; Novartis; Prothena
 
Angela Dispenzieri
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Alnylam (Inst); Celgene (Inst); Janssen Oncology (Inst); Pfizer (Inst); Prothena; Takeda (Inst)
Travel, Accommodations, Expenses - Janssen Oncology; Pfizer; Prothena
 
Suzanne Hayman
No Relationships to Disclose
 
Francis Buadi
No Relationships to Disclose
 
David Dingli
Consulting or Advisory Role - Alexion Pharmaceuticals; Bristol Myers Squibb Foundation; Janssen Biotech; MSD; Novartis; Sanofi
Research Funding - K36 Therapeutics (Inst)
 
Lisa Christenson
Consulting or Advisory Role - GlaxoSmithKline; Janssen; Pfizer (Inst); Shield Therapeutics
 
Amie Fonder
No Relationships to Disclose
 
Miriam Hobbs
No Relationships to Disclose
 
Michelle Rogers
No Relationships to Disclose
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tessera (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Nelson Leung
Stock and Other Ownership Interests - Abbvie; Senseonics; Verrica Pharmaceuticals
Research Funding - Omeros
 
Taxiarchis Kourelis
Research Funding - Novartis; Pfizer (Inst)
 
Rahma Warsame
Consulting or Advisory Role - Sanofi
 
Moritz Binder
No Relationships to Disclose
 
Nadine Abdallah
No Relationships to Disclose
 
S. Rajkumar
Honoraria - Medscape; Research to Practice
Patents, Royalties, Other Intellectual Property - Authorship Royalties from Up To Date
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Bristol-Myers Squibb/Celgene (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); K36 (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); MedImmune (Inst); Novartis (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Beigene; Janssen; Pfizer